Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | 17-AAG | 0.1 | uM | 10 | 2500.00 | 1067.09 | 5031.00 | 5136.00 | 0.9796 | 0.9819 |
| MDA-MB-231 | Lapatinib | 0.01 | uM | 10 | 2500.00 | 1067.09 | 4751.00 | 5136.00 | 0.9250 | 0.9324 |
| MDA-MB-231 | 0 | uM | 10 | 2500.00 | 1067.09 | 4917.00 | 5136.00 | 0.9574 | 0.9619 | |
| MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6306.00 | 6543.00 | 0.9638 | 0.9514 | |
| MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6193.00 | 6543.00 | 0.9465 | 0.9280 | |
| MDA-MB-231 | 17-AAG | 3.1623 | uM | 10 | 5000.00 | 2314.91 | 3744.00 | 6543.00 | 0.5722 | 0.3781 |
| MDA-MB-231 | Lapatinib | 0.0033113 | uM | 10 | 5000.00 | 2314.91 | 6214.00 | 6543.00 | 0.9497 | 0.9323 |
| MDA-MB-231 | Lapatinib | 0.031623 | uM | 10 | 5000.00 | 2314.91 | 6348.00 | 6543.00 | 0.9702 | 0.9600 |
| MDA-MB-231 | 17-AAG | 0.0033113 | uM | 10 | 5000.00 | 2314.91 | 6773.00 | 6543.00 | 1.0352 | 1.0466 |
| MDA-MB-231 | Linsitinib | 1 | uM | 10 | 5000.00 | 2314.91 | 6492.00 | 6543.00 | 0.9922 | 0.9896 |
| MDA-MB-231 | Lapatinib | 0.0016596 | uM | 10 | 5000.00 | 2314.91 | 6679.00 | 6543.00 | 1.0208 | 1.0276 |
| MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6756.00 | 6543.00 | 1.0326 | 1.0432 | |
| MDA-MB-231 | Linsitinib | 0.0033113 | uM | 10 | 5000.00 | 2314.91 | 6884.00 | 6543.00 | 1.0521 | 1.0689 |
| MDA-MB-231 | Linsitinib | 0.1 | uM | 10 | 5000.00 | 2314.91 | 6718.00 | 6543.00 | 1.0267 | 1.0355 |
| MDA-MB-231 | Lapatinib | 0.31623 | uM | 10 | 5000.00 | 2314.91 | 6742.00 | 6543.00 | 1.0304 | 1.0404 |
| MDA-MB-231 | Linsitinib | 0.031623 | uM | 10 | 5000.00 | 2314.91 | 6582.00 | 6543.00 | 1.0060 | 1.0079 |
| MDA-MB-231 | 17-AAG | 10 | uM | 10 | 5000.00 | 2314.91 | 2577.00 | 6543.00 | 0.3939 | 0.0742 |
| MDA-MB-231 | Lapatinib | 0.1 | uM | 10 | 5000.00 | 2314.91 | 6736.00 | 6543.00 | 1.0295 | 1.0392 |
| MDA-MB-231 | 17-AAG | 0.31623 | uM | 10 | 5000.00 | 2314.91 | 6501.00 | 6543.00 | 0.9936 | 0.9914 |
| MDA-MB-231 | Linsitinib | 10 | uM | 10 | 5000.00 | 2314.91 | 5246.00 | 6543.00 | 0.8018 | 0.7259 |
| MDA-MB-231 | Linsitinib | 0.31623 | uM | 10 | 5000.00 | 2314.91 | 6640.00 | 6543.00 | 1.0148 | 1.0197 |
| MDA-MB-231 | Erlotinib | 0.31623 | uM | 10 | 5000.00 | 2314.91 | 6660.00 | 6543.00 | 1.0179 | 1.0238 |
| MDA-MB-231 | Erlotinib | 3.1623 | uM | 10 | 5000.00 | 2314.91 | 6536.00 | 6543.00 | 0.9989 | 0.9986 |
| MDA-MB-231 | Erlotinib | 1 | uM | 10 | 5000.00 | 2314.91 | 6496.00 | 6543.00 | 0.9928 | 0.9904 |
| MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6580.00 | 6543.00 | 1.0057 | 1.0075 |